Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Grifols Expansion Plans Include Biotech Equity, New US Manufacturing Facilities

Executive Summary

Taking a 20% equity stake in US biotech Singulex and planning to build new manufacturing facilities in the US and Europe reflect the global expansion plans of Spain’s plasma product manufacturer Grifols, the third-largest in the world.

Advertisement

Related Content

BioNotebook: Targacept gone in reverse merger with Catalyst, plus five other deals

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register